StonvexLoading…
StonvexCore line items from TXT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q3 2020 2020-07-04 | Q2 2020 2020-04-04 | Annual 2020 2020-01-04 | Q3 2019 2019-09-28 |
|---|---|---|---|---|---|
Revenue | $3.83B | $5.25B | $2.78B | $13.63B | $9.60B |
Operating Income | Not available | $-49.00M | Not available | $942.00M | Not available |
Net Income | Not available | $-42.00M | $50.00M | $815.00M | $616.00M |
EPS (Diluted) | $1.56 | $-0.18 | $0.22 | $3.50 | $2.64 |
Total Assets | Not available | $15.47B | $15.95B | $15.02B | $15.06B |
Total Liabilities | Not available | $9.94B | $10.41B | $9.50B | $9.61B |
Cash & Equivalents | Not available | $2.35B | $2.45B | $1.36B | $1.05B |
Free Cash Flow OCF − CapEx | Not available | $-248.00M | $-445.00M | $675.00M | $7.00M |
Shares Outstanding | Not available | 227.95M | 227.38M | 227.96M | 228.24M |